Latest news with #Leech
Business Wire
08-07-2025
- Business
- Business Wire
Rosen Law Firm Urges Western Asset Management Company, LLC Mutual Fund Investors with Large Losses to Contact the Firm for Information About Their Rights
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces that an investor filed a class action lawsuit on behalf of purchasers of the 'Western Asset US Core Bond Fund' mutual fund classes – Class I (ticker: 'WATFX'), Class A (ticker: 'WABAX'), Class C (ticker: 'WABCX'), Class FI (ticker: 'WAPIX'), Class IS (ticker: 'WACSX'), and Class R (ticker: 'WABRX') – and the 'Western Asset Core Plus Bond Fund' mutual fund classes – Class A (ticker: 'WAPAX'), Class C (ticker: 'WAPCX'), Class C1 (ticker: 'LWCPX'), Class FI (ticker: 'WACIX'), Class R (ticker: 'WAPRX'), Class I (ticker: 'WACPX'), Class IS (ticker: 'WAPSX') between January 1, 2021 and October 31, 2023, inclusive (the 'Class Period'). Western Asset Management Company, LLC (or, 'WAMCO') offers investment products and investment management and advisory services. For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is Investigating the Allegations that Western Asset Management Company, LLC Misled Investors Regarding its Business Operations. According to the lawsuit, throughout the Class Period, defendants failed to warn investors that: (1) Defendants favored certain WAMCO strategies, like Macro Opps, over other WAMCO strategies, like Core and Core Plus; (2) Defendants disfavored certain WAMCO strategies, like Core and Core Plus; (3) any 'compliance policies and procedures' that WAMCO maintained 'to result in fair allocations of investment opportunities to clients' were either insufficient to ensure that Leech and his WAMCO Team fairly allocated trades among the strategies they managed or were expressly disregarded by defendants in order to allow the favoring of certain WAMCO strategies at the expense of other WAMCO strategies; (3) any 'oversight mechanisms' that WAMCO maintained were either insufficient to monitor Leech and his WAMCO Team or were expressly disregarded by Defendants in order to allow the favoring of certain WAMCO strategies at the expense of other WAMCO strategies. As a result, defendants' actions operated as a fraud or deceit on the Class, artificially reducing the price of the 'Western Asset US Core strategy' mutual fund classes during the Class Period, damaging Class members. What Now: You may be eligible to participate in the class action against Western Asset Management Company. Shareholders who want to serve as lead plaintiff for the class must file their motions with the court by September 5, 2025. A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here. All representation is on a contingency fee basis. Shareholders pay no fees or expenses. About Rosen Law Firm: Some law firms issuing releases about this matter do not actually litigate securities class actions. Rosen Law Firm does. Rosen Law Firm is a recognized leader in shareholder rights litigation, dedicated to helping shareholders recover losses, improving corporate governance structures, and holding company executives accountable for their wrongdoing. Since its inception, Rosen Law Firm has obtained over $1 billion for shareholders. Attorney Advertising. Prior results do not guarantee a similar outcome.
Business Wire
03-07-2025
- Business
- Business Wire
Scott+Scott Attorneys at Law LLP Files Securities Class Action Against Western Asset Management Company, LLC
NEW YORK--(BUSINESS WIRE)-- Scott+Scott Attorneys at Law LLP ('Scott+Scott'), an international shareholder and consumer rights litigation firm, has filed a securities class action lawsuit in the United States District Court for the Western District of Pennsylvania against Western Asset Management Company, LLC ('WAMCO' or the 'Company'), Franklin Resources, Inc. ('Franklin'), and Stephen Kenneth Leech, II ('Leech') (collectively, 'Defendants'). The Class Action asserts claims under §§10(b) and 20(a) of the Securities Exchange Act of 1934 (15 U.S.C. §§78j(b) and 78t(a)) and U.S. Securities and Exchange Commission Rule 10b-5 promulgated thereunder (17 C.F.R. §240.10b‑5) on behalf of all persons and entities that purchased and/or otherwise acquired shares of the 'Western Asset US Core Bond Fund' mutual fund classes – Class I (ticker: 'WATFX'), Class A (ticker: 'WABAX'), Class C (ticker: 'WABCX'), Class FI (ticker: 'WAPIX'), Class IS (ticker: 'WACSX'), and Class R (ticker: 'WABRX') – and the 'Western Asset Core Plus Bond Fund' mutual fund classes – Class A (ticker: 'WAPAX'), Class C (ticker: 'WAPCX'), Class C1 (ticker: 'LWCPX'), Class FI (ticker: 'WACIX'), Class R (ticker: 'WAPRX'), Class I (ticker: 'WACPX'), Class IS (ticker: 'WAPSX') – between January 1, 2021 and October 31, 2023, inclusive (the 'Class Period'), and were damaged thereby (the 'Class'). The Class Action filed by Scott+Scott is captioned: The Western PA Electrical Employees Insurance Trust Fund v. Western Asset Management Company, LLC, et al., Case No. 2:25-cv-00937. LEAD PLAINTIFF DEADLINE ON SEPTEMBER 2, 2025 WAMCO is a limited liability company, SEC-registered investment advisor, and specialist investment manager that is contracted by registered mutual funds and private funds to manage their investment portfolios and by other investment advisors as a sub-advisor. The Class Action alleges that, during the Class Period, Defendants made misleading statements and omissions regarding the Company's business, financial condition, and prospects. Specifically, Defendants failed to warn investors that: (1) Defendants favored certain WAMCO strategies, like Macro Opps, over other WAMCO strategies, like Core and Core Plus; (2) Defendants disfavored certain WAMCO strategies, like Core and Core Plus; (3) any 'compliance policies and procedures' that WAMCO maintained 'to result in fair allocations of investment opportunities to clients' were either insufficient to ensure that Leech and his WAMCO Team fairly allocated trades among the strategies they managed or were expressly disregarded by Defendants in order to allow the favoring of certain WAMCO strategies at the expense of other WAMCO strategies; and (4) any 'oversight mechanisms' that WAMCO maintained were either insufficient to monitor Leech and his WAMCO Team or were expressly disregarded by Defendants in order to allow the favoring of certain WAMCO strategies at the expense of other WAMCO strategies. As a result, Defendants' actions operated as a fraud or deceit on the Class, artificially reducing the price of the 'Western Asset US Core strategy' mutual fund classes during the Class Period, damaging Class members. LEAD PLAINTIFF DEADLINE ON SEPTEMBER 2, 2025 If you purchased and/or otherwise acquired shares of the 'Western Asset US Core Bond Fund' mutual fund classes identified above during the Class Period and were damaged thereby, you are a member of the 'Class' and may be able to seek appointment as lead plaintiff. If you wish to apply to be lead plaintiff, a motion on your behalf must be filed with the U.S. District Court for the Western District of Pennsylvania no later than September 2, 2025. The lead plaintiff is a court-appointed representative for absent class members of the Class. You do not need to seek appointment as lead plaintiff to share in any Class recovery in the Class Action. If you are a Class member and there is a recovery for the Class, you can share in that recovery as an absent Class member. If you wish to apply to be lead plaintiff, please contact attorney Nicholas Bruno at (888) 398-9312 or at nbruno@ What Can You Do? You may contact an attorney to discuss your rights regarding the appointment of lead plaintiff or your interest in the Class Action. You may retain counsel of your choice to represent you in the Class Action. About Scott+Scott Scott+Scott is an international law firm known for its expertise in representing corporate clients, institutional investors, businesses, and individuals harmed by anticompetitive conduct or other forms of wrongdoing, including securities law and shareholder violations. With more than 100 attorneys in eight offices in the United States, as well as three offices in Europe, our advocacy has resulted in significant monetary settlements on behalf of our clients, along with other forms of relief. Our highly experienced attorneys have been recognized for being among the top financial lawyers in 2024 by Lawdragon, WWL: Commercial Litigation 2024, and Legal 500 in Antitrust Civil Litigation, and have received top Chambers 2024 rankings. In addition, we have been repeatedly recognized by the American Antitrust Institute for the successful litigation of high-stakes anticompetitive claims in the United States. To learn more about Scott+Scott, our attorneys, or complex case resolution, please visit This may be considered Attorney Advertising.
Yahoo
10-06-2025
- Business
- Yahoo
GT Medical Technologies Names James Leech Chief Financial and Strategy Officer
Experienced Life Sciences Executive Joins Leadership Team as Company Further Advances Commercialization of GammaTile® TEMPE, Ariz., June 10, 2025 /PRNewswire/ -- GT Medical Technologies, a medical device company with a corporate purpose of improving the lives of patients with brain tumors, today announced that James Leech, a seasoned financial and operational life sciences leader, has joined the company as Chief Financial and Strategy Officer. "We are excited to welcome James as he assumes the Chief Financial and Strategy Officer role at GT Medical Technologies," said Per Langoe, CEO of GT Medical Technologies. "I look forward to collaborating with him to ensure even more doctors and patients have access to GammaTile®. With over 10 years of successful experience leading commercial-stage healthcare-focused companies in an advisory and operational capacity, his expertise on a range of traditional and complex financial and strategic management areas provides us with a substantial opportunity for continued growth and adoption." Mr. Leech will work across the team to accelerate commercial opportunities for GammaTile while spearheading corporate strategy and development, as well as financial and investor management. "I look forward to joining a leadership team that is dedicated to transforming the lives of patients with brain tumors," said Mr. Leech. "GT Medical Technologies is poised for significant growth, and I am thrilled to collaborate with all stakeholders to optimize the company's continued expansion of GammaTile, our FDA-cleared bioresorbable radiotherapy implant for the treatment of brain tumors." Mr. Leech has considerable experience leading businesses from inception through hyper growth phases of their life cycle. He has advised and worked across the life science industry with direct experience in MedTech, healthcare services, and biopharmaceutical sectors across all major therapeutic areas. Previously, Mr. Leech was the Chief Financial and Strategy Officer of Moximed, a commercial-stage orthopedic device company. Prior to Moximed, Mr. Leech was the Chief Business Officer at Palette Life Sciences from the Company's inception through its acquisition by Teleflex, Inc. Mr. Leech started his career in life science investment banking and strategy consulting. He brings significant cross-border experience, having executed transactions and operational initiatives on behalf of and involving companies across the EU and APAC. GammaTile is an innovative form of radiation therapy placed at the time of tumor removal surgery, delivering immediate, targeted radiation to the tumor site when cancer cells are most vulnerable. Unlike conventional approaches, which at their lowest often require a delay between surgery and radiation therapy to allow for wound healing, GammaTile eliminates this treatment gap. By delivering immediate, localized radiation directly at the tumor site, it is designed to maximize the treatment's effectiveness against remaining cancer cells and reduce the risk of regrowth.1 About GT Medical Technologies, Medical Technologies was founded by a dedicated team of brain tumor specialists to address unmet needs in brain tumor treatment. The company is committed to improving the lives of patients with brain tumors through innovative solutions that elevate the standard of care. About GammaTileGammaTile is an FDA-cleared, bioabsorbable collagen implant embedded with radiation seeds, designed for patients with operable brain tumors. By delivering radiation directly from within—placed into the surgical cavity at the time of tumor removal—GammaTile provides immediate, localized treatment. This approach targets remaining cancer cells when they are most vulnerable to help prevent regrowth, while minimizing radiation exposure to healthy brain tissue. Since its full market launch in the United States in March 2020, GammaTile has been adopted by more than 100 leading centers, underscoring its growing acceptance in both academic and community healthcare settings. For more information, visit and follow @GammaTile on Facebook, Instagram, LinkedIn and X. Media ContactDawn FallonNew Dawn Communications LLCDfallon@ References Garcia MA et al. J Neurooncol. 166:203-212 (2024). View original content to download multimedia: SOURCE GT Medical Technologies
USA Today
26-05-2025
- Business
- USA Today
Broncos president excited about possibility of stadium project
Broncos president excited about possibility of stadium project The Denver Broncos have not ruled out staying at Empower Field at Mile High, but there has been widespread speculation that the club will ultimately decide to build a new mega stadium that will attract future events like the Super Bowl. The Broncos have not made any announcement yet -- speculation of a new stadium is merely speculation -- but team president Damani Leech has admitted the thought of a new stadium project does excite him. 'I love this role, and I love this job," Leech said in March. "Part of what I love so much about it is making things better. Not just for myself, but for our staff and also for our fans. A stadium is a signature opportunity and moment to do that and be a part of it. "You talk to other colleagues who've been involved in stadium projects, and they talk about it. It's transformational for their career. It's a special moment. Given the life cycle of a stadium, you're lucky if you get a chance to be a part of it just once in your career. So that alone is pretty exciting.' The team's current stadium lease runs through the 2030 season, and it usually takes about four years to build a stadium. So if Denver opts to build a stadium from scratch, a decision might arrive soon. Leech will be eager to be at the forefront of that project, should the team decide to take that step. Related: These 25 celebrities are Broncos fans.
The Citizen
19-05-2025
- Sport
- The Citizen
Rynfield swimmer rakes in medals at African champs
Having shone as one of the standout performers at the 16th African Junior Swimming Championships in Cairo, Egypt, earlier this month, Rynfield resident Scarlett le Roux says she's looking forward to seeing what the future has in store for her. The distance swimmer raked in four gold medals in the 800m, 400m, and 200m freestyle and the 4x200m relay, and a silver in the 1 500m freestyle, propelling SA to the top of the standings with 52 medals – 25 golds, 17 silvers and 10 bronzes. It was a successful continental competition for the 17-year-old, closing out a fruitful championship with third overall in the women's points table. 'What made this sweet was that I went into the competition not ranked in the 1 500m, 800m, 400m and 200m. It was amazing,' Le Roux said. Among the highlights of her season was her performance at the 20th Africa Aquatics Zone IV Swimming and Open Water Championships in Namibia in December, captaining Team SA to a championship-winning 84 medals. She raked in 11 golds and a silver, and broke the 50m, 100m, 200m backstroke and 100m freestyle records to finish as the ages 15 to 16 Victrix Ludorum. The swimmer followed that up with seventh overall in the 400m freestyle and 10th in the 200m freestyle and 200m individual medley in the open races at her third SA national swimming champs in Gqeberha in April. Though she had set out to qualify for the World Aquatics Junior Swimming Champs in Romania in August, she was happy that she was in the top 10 in both events in the country. 'I wanted to see where I would rank in the country and what I could do. I hoped to make the junior world, but everything happens for a reason,' said Scarlett. 'It hasn't really hit me. I'm not glistening over being in the top 10. I'm always looking to be in the top three. I'm very proud of myself. I did better than I hoped. But I'm ready to be first in the country.' Le Roux's swimming took shape while a learner at Rynfield Primary but it was because of her current coach, Shirley Leech that she became the star she is. She said they instantly clicked when she met Leech as a seven-year-old, adding that Leech's mentorship made swimming more appealing. While her talent was clear from the start, Le Roux's success at her current level is attributed to her hard work, commitment, and dedication. 'I wasn't one of those children who got into the pool and people said, 'That's the next Olympian'. I worked my way up. I did it because I love it,' she said. Her mother, Lauren, described her as a focused and motivated athlete. 'She's self-motivated, and I think that's why she's done so well, because it's part of her personality. Peer pressure doesn't exist in her life. If she wants to do something, she goes out and does it. 'In the pool, there's a focus like nobody else. When she puts on her swimsuit, she switches to race mode. Nothing else exists. It's game time. It's a war zone,' Lauren said. While most would say their long-term goal is the Olympic Games, Le Roux has broken hers into small, achievable chunks. 'I would love to go to the Olympics, but I've never really set it as my goal. If I go to the worlds and do well, that would be my goal. I don't like to set long-term goals. I break everything down into achievable goals.' Also Read: Fairleads swimmer dreams of making a splash at the Olympics Also Read: Swimmer to make waves in Italy At Caxton, we employ humans to generate daily fresh news, not AI intervention. Happy reading!
